Loading...
Loading...
IPA| Name | Value |
|---|---|
| Revenues | 6,459.0K |
| Cost of Revenue | 3,351.0K |
| Gross Profit | 3,108.0K |
| Operating Expense | 6,624.0K |
| Operating I/L | -3,852.0K |
| Other Income/Expense | -15,306.0K |
| Interest Income | 0.0K |
| Pretax | -18,822.0K |
| Income Tax Expense | -777.0K |
| Net Income/Loss | -18,045.0K |
ImmunoPrecise Antibodies Ltd. is a leading provider of antibody production and related services globally. The company offers a diverse range of antibodies, enzymes, proteins, and hybridoma products for research purposes. Its contract research organization services encompass custom antigen modeling, B cell sorting, antibody engineering, and cell line generation. ImmunoPrecise Antibodies has research collaboration agreements with industry leaders for antibody discovery and high-concentration formulation of COVID-19 antibody cocktails. The company generates revenue through the sale of its antibody products, contract research services, and collaborative research agreements.
